Browsing by Title :

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:
  • Sort by:
  • In order:
  • Results/Page
  • Authors/Record:

Showing results 50121 to 50140 of 77249

This table browses all dspace content
Issue DateTitleJournal Title
2017Transverse dental compensation in relation to sagittal and transverse skeletal discrepancies in skeletal Class III patientsAMERICAN JOURNAL OF ORTHODONTICS AND DENTOFACIAL ORTHOPEDICS
2015Transverse testis ectopia: diagnostic and management algorithmINTERNATIONAL JOURNAL OF UROLOGY
2012Transvesicoscopic ureteral reimplantation in children with bilateral vesicoureteral reflux: surgical technique and resultsJOURNAL OF LAPAROENDOSCOPIC & ADVANCED SURGICAL TECHNIQUES
2023Trastuzumab Combined With Ramucirumab and Paclitaxel in Patients With Previously Treated Human Epidermal Growth Factor Receptor 2–Positive Advanced Gastric or Gastroesophageal Junction CancerJOURNAL OF CLINICAL ONCOLOGY
2022Trastuzumab deruxtecan (T-DXd; DS-8201) in patients with HER2-positive advanced gastric or gastroesophageal junction (GEJ) adenocarcinoma: Final overall survival (OS) results from a randomized, multicenter, open-label, phase 2 study (DESTINY-Gastric01)JOURNAL OF CLINICAL ONCOLOGY
2022Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast CancerNEW ENGLAND JOURNAL OF MEDICINE
2020Trastuzumab Deruxtecan in Previously Treated HER2-Positive Breast Cancer NEW ENGLAND JOURNAL OF MEDICINE
2020Trastuzumab Deruxtecan in Previously Treated HER2-Positive Gastric CancerNEW ENGLAND JOURNAL OF MEDICINE
2022Trastuzumab Deruxtecan versus Trastuzumab Emtansine for Breast CancerNEW ENGLAND JOURNAL OF MEDICINE
2017Trastuzumab emtansine versus taxane use for previously treated HER2-positive locally advanced or metastatic gastric or gastro-oesophageal junction adenocarcinoma (GATSBY): an international randomised, open-label, adaptive, phase 2/3 studyLANCET ONCOLOGY
2010Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial.LANCET
2023Trastuzumab plus FOLFOX for HER2-positive biliary tract cancer - Authors' replyLANCET GASTROENTEROLOGY & HEPATOLOGY
2023Trastuzumab plus FOLFOX for HER2-positive biliary tract cancer refractory to gemcitabine and cisplatin: a multi-institutional phase 2 trial of the Korean Cancer Study Group (KCSG-HB19-14)LANCET GASTROENTEROLOGY & HEPATOLOGY
2009Traumatic axillary ecchymoses in a golfer.CLINICAL AND EXPERIMENTAL DERMATOLOGY
2008Traumatic Experiences and Mental Health of North Korean Refugees in South Korea PSYCHIATRY INVESTIGATION
2013Traumatic Incus Dislocation Into the External Auditory CanalOTOLOGY & NEUROTOLOGY
2009Traumatic neuroma of the right hepatic duct undertaken right hemihepatectomyANZ JOURNAL OF SURGERY
2007Traumatic tricuspid regurgitation following cardiac massage JOURNAL OF KOREAN MEDICAL SCIENCE
2011Traumatic ventricular septal defect in a 4-year-old boy after blunt chest injury Korean Journal of Pediatrics
1980Trazodone이 가토 혈중 주정농도에 미치는 영향에 관한 실험적 연구Thesis

Browse

Links